Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. Jul 15, 2025; 17(7): 104402
Published online Jul 15, 2025. doi: 10.4251/wjgo.v17.i7.104402
Published online Jul 15, 2025. doi: 10.4251/wjgo.v17.i7.104402
Figure 7 mTOR pathway activation rescues the suppressive effects of flap endonuclease-1 knockdown on pancreatic cancer cell proliferation and migration.
A and B: Colony formation assays evaluating the proliferative capacity of flap endonuclease-1 (FEN1)-knockdown PATU8988T and PANC-1 cells following treatment with the AKT activator SC79; C and D: Transwell migration assays assessing the migratory potential of FEN1-knockdown PATU8988T and PANC-1 cells treated with SC79. Representative images and quantitative analysis of migrated cells are shown (data represent mean ± SD from three independent experiments). aP < 0.05, bP < 0.01, cP < 0.001.
- Citation: Xia Y, Guo N, Zhu CL, Gao JY, Da MX. Flap endonuclease-1 promotes pancreatic cancer progression via AKT/mTOR signaling pathway. World J Gastrointest Oncol 2025; 17(7): 104402
- URL: https://www.wjgnet.com/1948-5204/full/v17/i7/104402.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i7.104402